Literature DB >> 18837654

Role of oxidative stress in pancreatic inflammation.

Po Sing Leung1, Yuk Cheung Chan.   

Abstract

Reactive oxygen and reactive nitrogen species (ROS/RNS) have been implicated in the pathogenesis of acute and chronic pancreatitis. Clinical and basic science studies have indicated that ROS/RNS formation processes are intimately linked to the development of the inflammatory disorders. The detrimental effects of highly reactive ROS/RNS are mediated by their direct actions on biomolecules (lipids, proteins, and nucleic acids) and activation of proinflammatory signal cascades, which subsequently lead to activation of immune responses. The present article summarizes the possible sources of ROS/RNS formation and the detailed signaling cascades implicated in the pathogenesis of pancreatic inflammation, as observed in acute and chronic pancreatitis. A therapeutic ROS/RNS-scavenging strategy has been advocated for decades; however, clinical studies examining such approaches have been inconsistent in their results. Emerging evidence indicates that pancreatitis-inducing ROS/RNS generation may be attenuated by targeting ROS/RNS-generating enzymes and upstream mediators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18837654     DOI: 10.1089/ars.2008.2109

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  83 in total

1.  Oxymatrine ameliorates L-arginine-induced acute pancreatitis in rats.

Authors:  Zhiqiang Zhang; Yanqing Wang; Ming Dong; Jianchun Cui; Daqing Rong; Qi Dong
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

2.  Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

Authors:  Young Bin Hong; Hyo Jin Kang; Sun Young Kwon; Hee Jeong Kim; Kun Young Kwon; Chi Heum Cho; Jong-Min Lee; Bhaskar V S Kallakury; Insoo Bae
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

Review 3.  Organellar dysfunction in the pathogenesis of pancreatitis.

Authors:  Ilya Gukovsky; Stephen J Pandol; Anna S Gukovskaya
Journal:  Antioxid Redox Signal       Date:  2011-08-11       Impact factor: 8.401

4.  Alcohol and high fat induced chronic pancreatitis: TRPV4 antagonist reduces hypersensitivity.

Authors:  L P Zhang; R H Kline; G Deevska; F Ma; M Nikolova-Karakashian; K N Westlund
Journal:  Neuroscience       Date:  2015-10-19       Impact factor: 3.590

Review 5.  Pharmacologic therapy for acute pancreatitis.

Authors:  Swetha Kambhampati; Walter Park; Aida Habtezion
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 6.  Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review.

Authors:  Seyed Sajad Mohseni Salehi Monfared; Hamed Vahidi; Amir Hossein Abdolghaffari; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

7.  Glutathione peroxidase-1 inhibits transcription of regenerating islet-derived protein-2 in pancreatic islets.

Authors:  Jun-Won Yun; Zeping Zhao; Xi Yan; Marko Z Vatamaniuk; Xin Gen Lei
Journal:  Free Radic Biol Med       Date:  2019-01-28       Impact factor: 7.376

8.  Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Ameliorates Acute Pancreatitis.

Authors:  Lourdes Robles; Nosratola D Vaziri; Shiri Li; Yuichi Masuda; Chie Takasu; Mizuki Takasu; Kelly Vo; Seyed H Farzaneh; Michael J Stamos; Hirohito Ichii
Journal:  Pancreas       Date:  2016 May-Jun       Impact factor: 3.327

Review 9.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

10.  Chemopreventive effects of resveratrol in a rat model of cerulein-induced acute pancreatitis.

Authors:  Cristina Carrasco; María S Holguín-Arévalo; Gervasio Martín-Partido; Ana B Rodríguez; José A Pariente
Journal:  Mol Cell Biochem       Date:  2013-11-15       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.